B
Biorce
AI clinical-trial design and operations platform for life-science teams
About Biorce
Biorce is a Barcelona HealthTech company founded in 2024 that builds Aika, an AI platform for pharmaceutical companies, biotechs and CROs to design and operate clinical trials. Trained on a proprietary foundation of roughly one million trials, Aika supports protocol development, site selection and feasibility analysis while documenting recommendations for regulatory review and keeping experts in the loop; the company says it can reduce preparation timelines and protocol amendments across therapeutic areas including oncology, neurology and rare diseases. In February 2026 Biorce closed a €43.8 million ($52 million) Series A with DST Global Partners, Norrsken VC, YZR Capital, Mustard Seed Maze and angels, bringing total funding to more than €50.6 million ($60 million). Capital supports US expansion, hiring and new contract, budget and planning modules. Source: EU-Startups 2 Feb 2026.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2024
- Headquarters
- Barcelona, Spain
- Employees
- 140
- Open positions
- 89
- Dealroom signal
- 94.7/100
- Industry
- Health
- Sub-industry
- Pharmaceutical, Health Platform
- Sector
- Biotech & Life Sciences, Biotechnology, Drug Development, Core AI, Clinical Trials, Tech for Biotech and Pharma, Techbio, Techbio Drug Discovery
- Technology
- Artificial Intelligence, Deep Tech
- Business model
- SaaS
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES AOther financing | Feb 2026 | $52M | $208M | Norrsken VC · Mustard Seed MAZE · YZR Capital · Arthur Mensch | ↗ |
| SEEDOther financing | Jul 2025 | $5.5M | $22M | Norrsken VC | ↗ |
Growth signals
Latest recorded traffic for Biorce is 15K monthly website visits, down 31.8% over the last three months. Biorce's team grew 677.8% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
| Company | Headquarters | Status | Employees | Total funding | Valuation |
|---|---|---|---|---|---|
 iLoFAI and photonics platform for personalized drug discovery. |
London, United Kingdom | Operational | 40 | $13M | $22M |
 InatoAI-powered patient recruitment |
Paris, France | Operational | |||
 OmniscopeAI-powered immune databank for diagnostics and therapeutics |
Barcelona, Spain | Operational | |||
 PharmaceleraQuantum mechanics and AI powered drug discovery platform |
Barcelona, Spain | Operational | |||
 QuibimProducer of whole body radiological image analysis based on Artificial Intelligence |
Valencia, Spain | Operational | |||
 Keen EyeAnalyzes and reviews slide images |
Paris, France | Closed | |||
 PatchAiA cognitive platform embedding an empathetic virtual assistant for patient engagement and real-time conversational data collection |
Milan, Italy | Acquired | |||
 CastorA cloud-based clinical data platform that simplifies the clinical trial process |
New York City, United States | Operational |
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed5 investors entered at this stage
Mustard Seed MAZE
YZR Capital
Plug and Play
Outsized Ventures
Norrsken VC
Series A5 investors entered at this stage
DST Global
Arthur Mensch
Nikolay Storonsky
Paulo Rosado
Albert Nieto
Other known investors1 additional known investor
Google for Startups Accelerator
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Biorce on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Biorce’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.